Select Page

Anti-Human TNF alpha (Adalimumab) – PE – 50 µg

50 µg



ApplicationFA, FC, IF, IHC
ConjugateR-phycoerythrin (PE)
IsotypeHuman IgG1κ
ImmunogenHuman TNF alpha
Species ReactivityHuman
FormulationThis R-phycoerythrin (R-PE) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Research AreaCancer, Immunology
Description/BackgroundAdalimumab is a research-grade monoclonal antibody that works by inactivating tumor necrosis factor-alpha (TNF-α). TNF-α is a 17.5 kD protein that mediates inflammation and immunity caused by the invasion of viruses, bacteria, and parasites by initiating a cascade of cytokines that increase vascular permeability, thus bringing macrophages and neutrophils to the site of infection. TNF-α secreted by the macrophage causes the blood to clot which provides containment of the infection. TNF-α inactivation has proven to be important in downregulating the inflammatory reactions associated with autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, moderate to severe chronic psoriasis, and juvenile idiopathic arthritis. Adalimumab blocks the interaction with the p55 and p75 cell surface TNF receptors thus, neutralizing the biological function of TNF. Anti-Human TNF alpha (Adalimumab) utilizes the same variable regions from the therapeutic antibody Adalimumab making it ideal for research projects.
Storage TemperatureThis R-phycoerythrin (R-PE) conjugate is stable when stored at 2-8°C. Do not freeze.
ProtocolsFA, FC, IF, IHC
Clone NumberD2E7
Concentration0.2 mg/ml
Regulatory StatementFor Research Use Only. Not for use in diagnostic procedures.
50 µg